{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T01:24:28Z","timestamp":1779931468771,"version":"3.53.1"},"reference-count":22,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>\n                      Atypical apocrine adenosis (AAA) is a rare breast lesion defined as presence of cytologic atypia in apocrine adenosis.\n                      <jats:italic>World Health Organization Classification of Tumours<\/jats:italic>\n                      , 5th edition, defines cytologic atypia as at least 3-fold variation in nuclear size and prominent nucleoli. Currently, owing to the rarity of the lesion, the clinical behavior of AAA is not well understood.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To further investigate the risk of upgrade to malignant histology on follow-up excision after a diagnosis of isolated atypical apocrine adenosis (iAAA) on core needle biopsy (CNB).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>We identified 22 female patients with diagnosis of iAAA on CNBs across 3 institutions between 2000 and 2024, with an average age of 58 years. The most common indication for CNB was presence of a mass. We reviewed pathology reports and available histology slides of CNBs and subsequent surgical excisions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>Of 22 patients, 17 underwent surgical excision and 5 were followed up with mammogram for an average of 38 months. The diagnosis for 2 of 17 patients (12%) who underwent excision was upgraded to malignancy (ductal carcinoma in situ), 3 had atypical ductal hyperplasia (1 with AAA), and 2 additional patients had residual iAAA. iAAA was the target lesion in 7 of 21 cases (33%). Among these 7 cases, 5 patients presented with a mass; 2 of 5 (40%) were upgraded to DCIS and 1 of 5 had residual iAAA. The 5 patients who were followed up did not have any adverse outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>We recommend surgical excision of iAAA when found on CNB, especially when the target lesion is a mass. However, larger studies are necessary to further understand this entity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2024-0422-oa","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T05:39:42Z","timestamp":1754026782000},"page":"160-166","source":"Crossref","is-referenced-by-count":1,"title":["Outcomes on Excision and Clinical Follow-up of Isolated Atypical Apocrine Adenosis Diagnosed on Core Needle Biopsy: A Multi-institutional Study"],"prefix":"10.5858","volume":"150","author":[{"given":"Niloufar","family":"Pourfarrokh","sequence":"first","affiliation":[{"name":"From the Department of Pathology & Laboratory Medicine, Baylor Scott & White Medical Center, and Baylor College of Medicine (Temple Campus), Temple, Texas (Pourfarrokh, Asirvatham)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Nicholas","family":"Ateek","sequence":"additional","affiliation":[{"name":"the Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville (Ateek, Stewart)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Jorns","sequence":"additional","affiliation":[{"name":"the Department of Pathology, Medical College of Wisconsin, Milwaukee (Jorns)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Stewart","sequence":"additional","affiliation":[{"name":"the Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville (Ateek, Stewart)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya Ruth","family":"Asirvatham","sequence":"additional","affiliation":[{"name":"From the Department of Pathology & Laboratory Medicine, Baylor Scott & White Medical Center, and Baylor College of Medicine (Temple Campus), Temple, Texas (Pourfarrokh, Asirvatham)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","reference":[{"issue":"10","key":"i1543-2165-150-2-160-b01","series-title":"Arch Pathol Lab Med","first-page":"1045","article-title":"Atypical apocrine adenosis: diagnostic challenges and pitfalls","volume":"140","author":"Asirvatham","year":"2016","unstructured":"Asirvatham JR,\nFalcone MM,\nKleer CG. Atypical apocrine adenosis: diagnostic challenges and pitfalls. Arch Pathol Lab Med. 2016;140(10):1045\u20131051. doi:10.5858\/arpa.2016-0238-RA"},{"key":"i1543-2165-150-2-160-b02","series-title":"Ann Diagn Pathol","first-page":"4","article-title":"Surgical follow-up results for apocrine adenosis and atypical apocrine adenosis diagnosed on breast core biopsy","volume":"24","author":"Hou","year":"2016","unstructured":"Hou Y,\nChaudhary S,\nGao FF,\nLi Z. Surgical follow-up results for apocrine adenosis and atypical apocrine adenosis diagnosed on breast core biopsy. Ann Diagn Pathol. 2016;24:4\u20136. doi:10.1016\/j.anndiagpath.2016.07.001"},{"issue":"1","key":"i1543-2165-150-2-160-b03","series-title":"Virchows Arch","first-page":"177","article-title":"Apocrine lesions of the breast","volume":"480","author":"Quinn","year":"2022","unstructured":"Quinn CM,\nD\u2019Arcy C,\nWells C. Apocrine lesions of the breast. Virchows Arch. 2022;480(1):177\u2013189. doi:10.1007\/s00428-021-03185-4"},{"key":"i1543-2165-150-2-160-b04","article-title":"Breast Tumours. Lyon, France: International Agency for Research on Cancer; 2019","volume":"2","author":"WHO Classification of Tumours Editorial Board","unstructured":"WHO Classification of Tumours Editorial Board. Breast Tumours. Lyon, France: International Agency for Research on Cancer; 2019. WHO Classification of Tumours; 5th ed, vol 2. https:\/\/publications.iarc.fr\/581. Accessed June 24, 2024."},{"issue":"12","key":"i1543-2165-150-2-160-b05","series-title":"Cancer","first-page":"2529","article-title":"Atypical apocrine adenosis of the breast: a clinicopathologic study of 37 patients with 8.7-year follow-up","volume":"77","author":"Seidman","year":"1996","unstructured":"Seidman JD,\nAshton M,\nLefkowitz M. Atypical apocrine adenosis of the breast: a clinicopathologic study of 37 patients with 8.7-year follow-up. Cancer. 1996;77(12):2529\u20132537. doi:10.1002\/(SICI)1097-0142(19960615)77:12<2529::AID-CNCR16>3.0.CO;2-U"},{"issue":"2","key":"i1543-2165-150-2-160-b06","series-title":"Arch Pathol Lab Med","first-page":"179","article-title":"Atypical apocrine adenosis of the breast: long-term follow-up in 37 patients","volume":"136","author":"Fuehrer","year":"2012","unstructured":"Fuehrer N,\nHartmann L,\nDegnim A, et al. Atypical apocrine adenosis of the breast: long-term follow-up in 37 patients. Arch Pathol Lab Med. 2012;136(2):179\u2013182. doi:10.5858\/arpa.2011-0225-OA"},{"issue":"5","key":"i1543-2165-150-2-160-b07","series-title":"Breast J","first-page":"569","article-title":"Upgrade rate and imaging features of atypical apocrine lesions","volume":"23","author":"Chang Sen","year":"2017","unstructured":"Chang Sen LQ,\nBerg WA,\nCarter GJ. Upgrade rate and imaging features of atypical apocrine lesions. Breast J. 2017;23(5):569\u2013578. doi:10.1111\/tbj.12789"},{"issue":"3","key":"i1543-2165-150-2-160-b08","series-title":"Scand J Surg","first-page":"229","article-title":"Management and risk of upgrade of atypical ductal hyperplasia in the breast: a population-based retrospective cohort study","volume":"113","author":"Wadsten","year":"2024","unstructured":"Wadsten C,\nRask G. Management and risk of upgrade of atypical ductal hyperplasia in the breast: a population-based retrospective cohort study. Scand J Surg. 2024;113(3):229\u2013236. doi:10.1177\/14574969241234115"},{"issue":"8","key":"i1543-2165-150-2-160-b09","series-title":"J Ultrasound Med","first-page":"1517","article-title":"Ultrasound features and rate of upgrade to malignancy in atypical apocrine lesions of the breast","volume":"39","author":"Jung","year":"2020","unstructured":"Jung HK,\nKim SJ,\nKim W, et al. Ultrasound features and rate of upgrade to malignancy in atypical apocrine lesions of the breast. J Ultrasound Med. 2020;39(8):1517\u20131524. doi:10.1002\/jum.15240"},{"issue":"1","key":"i1543-2165-150-2-160-b10","series-title":"Mod Pathol","first-page":"1","article-title":"Atypical apocrine metaplasia in sclerosing lesions of the breast: a study of 51 patients","volume":"4","author":"Carter","year":"1991","unstructured":"Carter DJ,\nRosen PP. Atypical apocrine metaplasia in sclerosing lesions of the breast: a study of 51 patients. Mod Pathol. 1991;4(1):1\u20135."},{"issue":"10","key":"i1543-2165-150-2-160-b11","series-title":"Hum Pathol","first-page":"2130","article-title":"Atypical apocrine adenosis diagnosed on breast core biopsy: implications for management","volume":"45","author":"Calhoun","year":"2014","unstructured":"Calhoun BC,\nBooth CN. Atypical apocrine adenosis diagnosed on breast core biopsy: implications for management. Hum Pathol. 2014;45(10):2130\u20132135. doi:10.1016\/j.humpath.2014.06.010"},{"issue":"10","key":"i1543-2165-150-2-160-b01","series-title":"Arch Pathol Lab Med","first-page":"1045","article-title":"Atypical apocrine adenosis: diagnostic challenges and pitfalls","volume":"140","author":"Asirvatham","year":"2016","unstructured":"Asirvatham JR,\nFalcone MM,\nKleer CG. Atypical apocrine adenosis: diagnostic challenges and pitfalls. Arch Pathol Lab Med. 2016;140(10):1045\u20131051. doi:10.5858\/arpa.2016-0238-RA"},{"key":"i1543-2165-150-2-160-b02","series-title":"Ann Diagn Pathol","first-page":"4","article-title":"Surgical follow-up results for apocrine adenosis and atypical apocrine adenosis diagnosed on breast core biopsy","volume":"24","author":"Hou","year":"2016","unstructured":"Hou Y,\nChaudhary S,\nGao FF,\nLi Z. Surgical follow-up results for apocrine adenosis and atypical apocrine adenosis diagnosed on breast core biopsy. Ann Diagn Pathol. 2016;24:4\u20136. doi:10.1016\/j.anndiagpath.2016.07.001"},{"issue":"1","key":"i1543-2165-150-2-160-b03","series-title":"Virchows Arch","first-page":"177","article-title":"Apocrine lesions of the breast","volume":"480","author":"Quinn","year":"2022","unstructured":"Quinn CM,\nD\u2019Arcy C,\nWells C. Apocrine lesions of the breast. Virchows Arch. 2022;480(1):177\u2013189. doi:10.1007\/s00428-021-03185-4"},{"key":"i1543-2165-150-2-160-b04","article-title":"Breast Tumours. Lyon, France: International Agency for Research on Cancer; 2019","volume":"2","author":"WHO Classification of Tumours Editorial Board","unstructured":"WHO Classification of Tumours Editorial Board. Breast Tumours. Lyon, France: International Agency for Research on Cancer; 2019. WHO Classification of Tumours; 5th ed, vol 2. https:\/\/publications.iarc.fr\/581. Accessed June 24, 2024."},{"issue":"12","key":"i1543-2165-150-2-160-b05","series-title":"Cancer","first-page":"2529","article-title":"Atypical apocrine adenosis of the breast: a clinicopathologic study of 37 patients with 8.7-year follow-up","volume":"77","author":"Seidman","year":"1996","unstructured":"Seidman JD,\nAshton M,\nLefkowitz M. Atypical apocrine adenosis of the breast: a clinicopathologic study of 37 patients with 8.7-year follow-up. Cancer. 1996;77(12):2529\u20132537. doi:10.1002\/(SICI)1097-0142(19960615)77:12<2529::AID-CNCR16>3.0.CO;2-U"},{"issue":"2","key":"i1543-2165-150-2-160-b06","series-title":"Arch Pathol Lab Med","first-page":"179","article-title":"Atypical apocrine adenosis of the breast: long-term follow-up in 37 patients","volume":"136","author":"Fuehrer","year":"2012","unstructured":"Fuehrer N,\nHartmann L,\nDegnim A, et al. Atypical apocrine adenosis of the breast: long-term follow-up in 37 patients. Arch Pathol Lab Med. 2012;136(2):179\u2013182. doi:10.5858\/arpa.2011-0225-OA"},{"issue":"5","key":"i1543-2165-150-2-160-b07","series-title":"Breast J","first-page":"569","article-title":"Upgrade rate and imaging features of atypical apocrine lesions","volume":"23","author":"Chang Sen","year":"2017","unstructured":"Chang Sen LQ,\nBerg WA,\nCarter GJ. Upgrade rate and imaging features of atypical apocrine lesions. Breast J. 2017;23(5):569\u2013578. doi:10.1111\/tbj.12789"},{"issue":"3","key":"i1543-2165-150-2-160-b08","series-title":"Scand J Surg","first-page":"229","article-title":"Management and risk of upgrade of atypical ductal hyperplasia in the breast: a population-based retrospective cohort study","volume":"113","author":"Wadsten","year":"2024","unstructured":"Wadsten C,\nRask G. Management and risk of upgrade of atypical ductal hyperplasia in the breast: a population-based retrospective cohort study. Scand J Surg. 2024;113(3):229\u2013236. doi:10.1177\/14574969241234115"},{"issue":"8","key":"i1543-2165-150-2-160-b09","series-title":"J Ultrasound Med","first-page":"1517","article-title":"Ultrasound features and rate of upgrade to malignancy in atypical apocrine lesions of the breast","volume":"39","author":"Jung","year":"2020","unstructured":"Jung HK,\nKim SJ,\nKim W, et al. Ultrasound features and rate of upgrade to malignancy in atypical apocrine lesions of the breast. J Ultrasound Med. 2020;39(8):1517\u20131524. doi:10.1002\/jum.15240"},{"issue":"1","key":"i1543-2165-150-2-160-b10","series-title":"Mod Pathol","first-page":"1","article-title":"Atypical apocrine metaplasia in sclerosing lesions of the breast: a study of 51 patients","volume":"4","author":"Carter","year":"1991","unstructured":"Carter DJ,\nRosen PP. Atypical apocrine metaplasia in sclerosing lesions of the breast: a study of 51 patients. Mod Pathol. 1991;4(1):1\u20135."},{"issue":"10","key":"i1543-2165-150-2-160-b11","series-title":"Hum Pathol","first-page":"2130","article-title":"Atypical apocrine adenosis diagnosed on breast core biopsy: implications for management","volume":"45","author":"Calhoun","year":"2014","unstructured":"Calhoun BC,\nBooth CN. Atypical apocrine adenosis diagnosed on breast core biopsy: implications for management. Hum Pathol. 2014;45(10):2130\u20132135. doi:10.1016\/j.humpath.2014.06.010"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/150\/2\/article-p160.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/doi\/10.5858\/arpa.2024-0422-OA\/3533161\/10.5858_arpa.2024-0422-oa.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/150\/2\/article-p160.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/150\/2\/article-p160.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:14:14Z","timestamp":1770772454000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/150\/2\/article-p160.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":22,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.5858\/arpa.2024-0422-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]}}}